How COVID-19 reshaped 21st Century Cures Act enforcement

Back in March, new rules mandating how health systems must improve their interoperability methods were published by the Department of Health and Human Services. In a new white paper, IMO’s Chief Medical Officer, Andrew S. Kanter, MD, explores how the coronavirus pandemic has changed the plans for implementation and revealed gaps in the legislation.
Published
Written by
Picture of IMO Health
Staff

In 2016, the 21st Century Cures Act put the spotlight on healthcare’s need for increased interoperability. When Final Rules were passed in March, their goal was to enforce the Act’s mandates as quickly as possible. Now, COVID-19 has not only highlighted the urgent need for this data sharing, but has also taxed health systems like never before.

Even prior to the pandemic, the Rules set forth an ambitious timeline for compliance with the new regulations – a mere six months for certain elements. In early spring, some health systems were already raising concerns that this time frame was too aggressive, arguing that they placed institutions with fewer resources at a disadvantage.

In IMO’s latest white paper, we take a look at how COVID-19 has impacted the implementation of the Cures Act – from adjusting the due dates, to underscoring the critical importance of increasing and improving data sharing as quickly as possible.

To download The 21st Century Cures Act in the age of COVID-19, click on the button below.

Related Content

Blog digest signup

Resources sent straight to your inbox.

Latest Resources​

The addition of USCDI v3 and v4 to IMO Health’s proprietary lexicon ensures health systems comply with rapidly evolving regulations, avoiding costly...
Make your healthcare AI investments count. Learn why clinical context and grounding is essential for safe, accurate, and usable model outputs.
Smarter EHR workflows. Better data. More accurate reimbursement.